vs
RGC RESOURCES INC（RGCO）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是RGC RESOURCES INC的1.2倍（$35.5M vs $30.6M），RGC RESOURCES INC净利率更高（16.0% vs -304.2%，领先320.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 13.9%），RGC RESOURCES INC自由现金流更多（$-4.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -0.4%）
伊鲁卡资源是一家澳大利亚资源企业，专注于砂矿勘探、项目开发、运营与营销。该公司在1998年7月由西澳砂矿公司与RGC有限公司的钛矿物业务合并而成，1999年正式定名为伊鲁卡资源有限公司。它是全球主要的锆石、二氧化钛衍生金红石及合成金红石生产商，在澳大利亚拥有运营业务，也曾在美国等地区开展业务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
RGCO vs RXRX — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.6M | $35.5M |
| 净利润 | $4.9M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 21.4% | -304.8% |
| 净利率 | 16.0% | -304.2% |
| 营收同比 | 13.9% | 681.7% |
| 净利润同比 | -7.3% | 39.6% |
| 每股收益（稀释后） | $0.47 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $30.6M | $35.5M | ||
| Q3 25 | $14.0M | $5.2M | ||
| Q2 25 | $16.6M | $19.2M | ||
| Q1 25 | $36.5M | $14.7M | ||
| Q4 24 | $26.8M | $4.5M | ||
| Q3 24 | $12.8M | $26.1M | ||
| Q2 24 | $13.6M | $14.4M | ||
| Q1 24 | $30.8M | $13.8M |
| Q4 25 | $4.9M | $-108.1M | ||
| Q3 25 | $-204.3K | $-162.3M | ||
| Q2 25 | $538.4K | $-171.9M | ||
| Q1 25 | $7.7M | $-202.5M | ||
| Q4 24 | $5.3M | $-178.9M | ||
| Q3 24 | $140.8K | $-95.8M | ||
| Q2 24 | $156.7K | $-97.5M | ||
| Q1 24 | $6.4M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 21.4% | -304.8% | ||
| Q3 25 | -3.4% | -3327.6% | ||
| Q2 25 | 7.2% | -916.8% | ||
| Q1 25 | 28.5% | -1297.9% | ||
| Q4 24 | 27.3% | -4042.4% | ||
| Q3 24 | 1.9% | -377.1% | ||
| Q2 24 | 11.5% | -697.4% | ||
| Q1 24 | 28.0% | -698.4% |
| Q4 25 | 16.0% | -304.2% | ||
| Q3 25 | -1.5% | -3135.3% | ||
| Q2 25 | 3.2% | -894.2% | ||
| Q1 25 | 21.1% | -1373.3% | ||
| Q4 24 | 19.6% | -3935.5% | ||
| Q3 24 | 1.1% | -367.5% | ||
| Q2 24 | 1.2% | -676.6% | ||
| Q1 24 | 20.9% | -662.4% |
| Q4 25 | $0.47 | $-0.17 | ||
| Q3 25 | $-0.01 | $-0.36 | ||
| Q2 25 | $0.05 | $-0.41 | ||
| Q1 25 | $0.74 | $-0.50 | ||
| Q4 24 | $0.51 | $-0.56 | ||
| Q3 24 | $0.01 | $-0.34 | ||
| Q2 24 | $0.02 | $-0.40 | ||
| Q1 24 | $0.63 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $116.4M | $1.1B |
| 总资产 | $341.0M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $116.4M | $1.1B | ||
| Q3 25 | $113.6M | $1.0B | ||
| Q2 25 | $116.3M | $919.1M | ||
| Q1 25 | $117.8M | $933.9M | ||
| Q4 24 | $111.8M | $1.0B | ||
| Q3 24 | $108.1M | $524.6M | ||
| Q2 24 | $108.8M | $584.4M | ||
| Q1 24 | $110.5M | $401.2M |
| Q4 25 | $341.0M | $1.5B | ||
| Q3 25 | $329.8M | $1.4B | ||
| Q2 25 | $324.8M | $1.3B | ||
| Q1 25 | $326.4M | $1.3B | ||
| Q4 24 | $335.2M | $1.4B | ||
| Q3 24 | $320.7M | $726.5M | ||
| Q2 24 | $314.2M | $775.9M | ||
| Q1 24 | $313.4M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-4.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | -14.9% | -133.1% |
| 资本支出强度资本支出/营收 | 18.5% | 3.5% |
| 现金转化率经营现金流/净利润 | 0.22× | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $1.1M | $-46.1M | ||
| Q3 25 | $675.1K | $-117.4M | ||
| Q2 25 | $6.4M | $-76.4M | ||
| Q1 25 | $21.0M | $-132.0M | ||
| Q4 24 | $827.2K | $-115.4M | ||
| Q3 24 | $377.4K | $-59.2M | ||
| Q2 24 | $5.9M | $-82.2M | ||
| Q1 24 | $11.8M | $-102.3M |
| Q4 25 | $-4.6M | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | $1.4M | $-79.6M | ||
| Q1 25 | $16.1M | $-133.8M | ||
| Q4 24 | $-4.9M | $-116.7M | ||
| Q3 24 | $-5.1M | $-63.8M | ||
| Q2 24 | $564.7K | $-83.4M | ||
| Q1 24 | $5.8M | $-109.0M |
| Q4 25 | -14.9% | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | 8.4% | -413.9% | ||
| Q1 25 | 44.1% | -907.4% | ||
| Q4 24 | -18.3% | -2567.7% | ||
| Q3 24 | -40.2% | -244.6% | ||
| Q2 24 | 4.2% | -578.5% | ||
| Q1 24 | 18.8% | -789.9% |
| Q4 25 | 18.5% | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | 30.4% | 16.4% | ||
| Q1 25 | 13.6% | 12.4% | ||
| Q4 24 | 21.4% | 28.6% | ||
| Q3 24 | 43.2% | 17.5% | ||
| Q2 24 | 39.0% | 8.2% | ||
| Q1 24 | 19.4% | 48.2% |
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 11.96× | — | ||
| Q1 25 | 2.74× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 2.68× | — | ||
| Q2 24 | 37.36× | — | ||
| Q1 24 | 1.83× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
